Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancer (Q34368408)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancer |
scientific article |
Statements
1 reference
Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancer (English)
1 reference
Steven M Larson
Howard I Scher
Josef J Fox
Michael J Morris
Daniel C Danila
Jeffrey H Hager
Peter J Rix
Edna Chow Maneval
Isan Chen
Mithat Gönen
Martin Fleisher
Charles L Sawyers
3 September 2013
1 reference